摘要
Snake venoms are a rich and diverse source of pharmacologically active compounds with immense potential in biomedical applications, including drug discovery. In cancer research, the bioactive molecules in snake venom—particularly snake venom metalloproteinases (SVMPs) and snake venom serine proteases (SVSPs)—have emerged as potential agents for cancer therapy. SVMPs, which are known to target extracellular matrix components and integrins, can disrupt tumor microenvironments and inhibit cancer cell adhesion, migration, and angiogenesis, making them potent anticancer agents. These metalloproteinases also activate intrinsic and extrinsic pathways that lead to apoptosis and tumor suppression. SVSPs exhibit unique anticancer properties by inhibiting tumor cell proliferation, inducing cell death, and preventing metastasis. Together, these venom-derived proteases offer promising avenues for novel cancer treatments due to their ability to target key molecular pathways involved in tumor progression. In drug design, these molecules can serve as templates for novel cancer therapies with minimized adverse effects and the ability to overcome resistance. This chapter provides an overview of recent development in this topic, and concludes with a forward-looking discussion on the future need for more in-depth research to unleash the potential of these proteins as targeted cancer treatment.